Search PDMR transactions

Notifier
Name of person with notification obligation
Mathias Svahn
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mathias Svahn
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share NextCell Pharma AB SE0022240867 Disposal 11,000 Quantity 1.4211 SEK 18/06/2024 NASDAQ STOCKHOLM AB
BTU NextCell Pharma BTU SE0022240867 Acquisition 12,526 Quantity 1.419 SEK 18/06/2024 NASDAQ STOCKHOLM AB
Share NextCell Pharma AB SE0022240867 Disposal 5,000 Quantity 1.50 SEK 19/06/2024 NASDAQ STOCKHOLM AB
BTU NextCell Pharma AB BTU SE0022240867 Acquisition 10,000 Quantity 1.54 SEK 19/06/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma AB SE0022240867 Disposal 18/06/2024 NASDAQ STOCKHOLM AB 11,000 (Quantity) 1.4211 SEK
NextCell Pharma BTU SE0022240867 Acquisition 18/06/2024 NASDAQ STOCKHOLM AB 12,526 (Quantity) 1.419 SEK
NextCell Pharma AB SE0022240867 Disposal 19/06/2024 NASDAQ STOCKHOLM AB 5,000 (Quantity) 1.50 SEK
NextCell Pharma AB BTU SE0022240867 Acquisition 19/06/2024 NASDAQ STOCKHOLM AB 10,000 (Quantity) 1.54 SEK
<< Back